Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M de Boer

Showing results (521-530 of 719) with videos related to

Pageof 72
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancerJ E Portielje, W H Kruit, M Schuler, et al.
Journal of the American Society of Nephrology : JASN|November 18, 2005
Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injuryJoris J T H Roelofs, Kasper M A Rouschop, Jaklien C Leemans, et al.
European Journal of Cancer Care|October 13, 2017
Development of a tailored work-related support intervention for gastrointestinal cancer patientsAnne-Claire G N M Zaman, Kristien M A J Tytgat, Sanne van Hezel, et al.
Clinical and Experimental Immunology|March 1, 1997
CD8+ cells and not CD4+ T cells are hyporesponsive to CD28- and CD40L-mediated activation in HIV-infected subjectsJ Vingerhoets, L Kestens, G Penne, et al.
American Journal of Industrial Medicine|July 25, 2008
Sentinel surveillance of occupational diseases: a quality improvement projectD Spreeuwers, A G E M de Boer, J H A M Verbeek, et al.
BMC Health Services Research|February 10, 2022
Impact of COVID-19 pandemic on diagnostic pathology in the NetherlandsM L F van Velthuysen, S van Eeden, S le Cessie, et al.
British Journal of Cancer|January 1, 1997
B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's diseaseW C Vooijs, H G Otten, M van Vliet, et al.
The American Journal of Cardiology|November 9, 2010
Impact of clinical presentation and pretest likelihood on the relation between calcium score and computed tomographic coronary angiographyJacob M van Werkhoven, Stephanie M de Boer, Joanne D Schuijf, et al.
Critical Care Medicine|January 21, 2006
Effects of prolonged intensive care unit stay on quality of life and long-term survival after transthoracic esophageal resectionH A Cense, J B F Hulscher, A G E M de Boer, et al.
International Journal of Cardiology|October 23, 2013
Trial participation as a determinant of clinical outcome: differences between trial-participants and Every Day Clinical Care patients in the field of interventional cardiologySanneke P M de Boer, Maarten A H van Leeuwen, Jin M Cheng, et al.
Pageof 72

Showing results (521-530 of 719) with videos related to

Sort By:
Pageof 72
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancerJ E Portielje, W H Kruit, M Schuler, et al.
Journal of the American Society of Nephrology : JASN|November 18, 2005
Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injuryJoris J T H Roelofs, Kasper M A Rouschop, Jaklien C Leemans, et al.
European Journal of Cancer Care|October 13, 2017
Development of a tailored work-related support intervention for gastrointestinal cancer patientsAnne-Claire G N M Zaman, Kristien M A J Tytgat, Sanne van Hezel, et al.
Clinical and Experimental Immunology|March 1, 1997
CD8+ cells and not CD4+ T cells are hyporesponsive to CD28- and CD40L-mediated activation in HIV-infected subjectsJ Vingerhoets, L Kestens, G Penne, et al.
American Journal of Industrial Medicine|July 25, 2008
Sentinel surveillance of occupational diseases: a quality improvement projectD Spreeuwers, A G E M de Boer, J H A M Verbeek, et al.
BMC Health Services Research|February 10, 2022
Impact of COVID-19 pandemic on diagnostic pathology in the NetherlandsM L F van Velthuysen, S van Eeden, S le Cessie, et al.
British Journal of Cancer|January 1, 1997
B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's diseaseW C Vooijs, H G Otten, M van Vliet, et al.
The American Journal of Cardiology|November 9, 2010
Impact of clinical presentation and pretest likelihood on the relation between calcium score and computed tomographic coronary angiographyJacob M van Werkhoven, Stephanie M de Boer, Joanne D Schuijf, et al.
Critical Care Medicine|January 21, 2006
Effects of prolonged intensive care unit stay on quality of life and long-term survival after transthoracic esophageal resectionH A Cense, J B F Hulscher, A G E M de Boer, et al.
International Journal of Cardiology|October 23, 2013
Trial participation as a determinant of clinical outcome: differences between trial-participants and Every Day Clinical Care patients in the field of interventional cardiologySanneke P M de Boer, Maarten A H van Leeuwen, Jin M Cheng, et al.
Pageof 72